ArticlePloS one2017

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

Yuko Nagaoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.